A group of molecules discovered in prostate cancer cells could distinguish which patients should be treated with radiation therapy following surgical removal of the prostate.

nuclear imaging, overuse, CT, regional, U.S., breast, prostate, cancer

Where you receive medical care impacts many things - including whether or not you receive inappropriate medical tests, according to a new study.

Unfors RaySafe released a new radiation survey sensor at the 2015 European Congress of Radiology (ECR) in Vienna, Austria.

RaySafe X2 Survey Sensor

Hitachi Aloka Medical Ltd. announced the release of EggQus — a compact, portable ultrasound bone densitometry system — at the 2015 European Radiology Congress (ECR).

light therapy, radiation oncology, radiopharmaceuticals, PET

Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis have devised a way to apply light-based therapy to deep tissues never before accessible. Instead of shining an outside light, they delivered light directly to tumor cells, along with a photosensitive source of free radicals that can be activated by the light to destroy cancer. And they accomplished this using materials already approved for use in cancer patients.

The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the treatment of prostate and bone cancers – reached EUR 157 million (US$ 209 million) in 2014.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now